Stocks and Investing
Stocks and Investing
Fri, August 7, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Lewis Maintained (TMDX) at Hold with Increased Target to $18 on, Aug 7th, 2020
David Lewis of Morgan Stanley, Maintained "TransMedics Group, Inc." (TMDX) at Hold with Increased Target from $15 to $18 on, Aug 7th, 2020.
David has made no other calls on TMDX in the last 4 months.
There are 2 other peers that have a rating on TMDX. Out of the 2 peers that are also analyzing TMDX, 0 agree with David's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with David
- Jason Mills of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $20 on, Thursday, August 6th, 2020
- Suraj Kalia of "Oppenheimer" Initiated at Buy and Held Target at $25 on, Tuesday, April 7th, 2020